Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GILOTRIF vs GIVOSIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GILOTRIF vs GIVOSIRAN: Safety Overview

Metric GILOTRIF GIVOSIRAN
Total FAERS Reports 117 1,224
Deaths Reported 35 32
Death Rate 29.9% 2.6%
Hospitalizations 29 595
Average Patient Age 64.9 yrs 45.1 yrs
% Female Patients N/A 89.5%
FDA Approval Date N/A Nov 20, 2019
Manufacturer N/A Alnylam Pharmaceuticals, Inc.
Route N/A SUBCUTANEOUS
Marketing Status N/A Prescription